Literature DB >> 2484680

Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions.

P Ekblom1, E Aufderheide.   

Abstract

Tenascin is an extracellular matrix glycoprotein with an unusually restricted tissue distribution in the developing embryo. The protein was independently discovered by several investigators, and has been given many different names. Synonyms of tenascin include cytotactin, J1, hexabrachion and glioma-mesenchymal extracellular matrix antigen. Whereas fibronectin is expressed rather uniformly in matrices of embryonic mesenchyme, tenascin is found in the mesenchyme at sites of epithelial-mesenchymal interactions. Tenascin is thus found close to epithelial basement membranes but it is probably not an integral basement membrane component. The distribution suggests that developing epithelial cells may produce locally active factors that stimulate tenascin synthesis in the nearby mesenchyme. Tenascin is composed of disulfide-bonded subunits of approximate Mr between 200-280 kD. Using monoclonal antibodies to mouse tenascin, we find two major subunits of Mr 260 and 200 kD from mouse fibroblasts. Work from many laboratories suggests that the different subunits arise by differential splicing of one mRNA. Rotary shadowing electron microscopy of the intact molecule suggests a six-armed structure connected by a central region. However, the different subunits are not co-ordinately expressed during embryogenesis, suggesting that tenascin can exist as different isoforms. The different isoforms may serve distinct functions. The function of tenascin is not well known, but it has been suggested that it alters the adhesive properties of cells and causes cell rounding.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484680

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  19 in total

1.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

2.  Tenascin distribution in human brain tumours.

Authors:  P Castellani; A Dorcaratto; A Siri; L Zardi; G L Viale
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.

Authors:  P L Jones; K N Cowan; M Rabinovitch
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Melanoma Cell Invasive and Metastatic Potential Correlates with Endothelial Cell Reorganization and Tenascin Expression.

Authors:  P Sriramarao; Mario A Bourdon
Journal:  Endothelium       Date:  1996

5.  Differential expression of tenascin-C in the developing human lung: an immunohistochemical study.

Authors:  M Lambropoulou; V Limberis; N Koutlaki; M Simopoulou; D Ntanovasilis; G P Vandoros; P Tatsidou; I Kekou; I Koutsikogianni; N Papadopoulos
Journal:  Clin Exp Med       Date:  2009-07-21       Impact factor: 3.984

Review 6.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

7.  The extracellular matrix in sarcomatoid carcinomas of the breast.

Authors:  M Guarino; D Reale; G Micoli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo.

Authors:  C H Damsky; M L Fitzgerald; S J Fisher
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

9.  GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts.

Authors:  Angela Ghatnekar; Maria Trojanowska
Journal:  Biochim Biophys Acta       Date:  2007-12-14

10.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.

Authors:  P Tremble; R Chiquet-Ehrismann; Z Werb
Journal:  Mol Biol Cell       Date:  1994-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.